Dhammika Nanayakkara
University of Mississippi
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Dhammika Nanayakkara.
Phytochemistry | 2002
Giovanni Meazza; Brian E. Scheffler; Mario R. Tellez; Agnes M. Rimando; Joanne G. Romagni; Stephen O. Duke; Dhammika Nanayakkara; Ikhlas A. Khan; Ehab A. Abourashed; Franck E. Dayan
The inhibitory activity of 34 natural products of various structural classes on hydroxyphenylpyruvate dioxygenase (HPPD), the target site for triketone herbicides, and the mode of interaction of selected natural products were investigated. Recombinant HPPD from arabidopsis is sensitive to several classes of natural compounds including, in decreasing order of sensitivity, triketones, benzoquinones, naphthoquinones and anthraquinones. The triketone natural products acted as competitive tight-binding inhibitors, whereas the benzoquinones and naphthoquinones did not appear to bind tightly to HPPD. While these natural products may not have optimal structural features required for in vivo herbicidal activity, the differences in their kinetic behavior suggest that novel classes of HPPD inhibitors may be developed based on their structural backbones.
BioMed Research International | 2013
Andrey Pereira Lopes; Bianca Souza Bagatela; Paulo César Pires Rosa; Dhammika Nanayakkara; José Carlos Tavares Carvalho; Edson Luis Maistro; Jairo Kenupp Bastos; Fabio Ferreira Perazzo
The crude ethanolic extract from aerial parts of Pothomorphe umbellata L. (Piperaceae) and fractions obtained by partitions sequentially among water-methanol, methylene chloride, and ethyl acetate, as well as the major constituent, 4-nerolidylcatechol, were, respectively, evaluated and evidenced for antioxidant and cytotoxic effects through fluorometric microplate and microculture tetrazolium assays in HL-60 cells. The crude ethanolic extract demonstrated the preeminent antioxidant activity (IC50 = 1.2 μg/mL) against exogenous cytoplasmic reactive oxygen species, followed by the water-methanolic (IC50 = 4.5 μg/mL), methylene chloride (IC50 = 5.9 μg/mL), ethyl acetate (IC50 = 8.0 μg/mL), 4-nerolidylcatechol (IC50 = 8.6 μg/mL), and the sterol fractions (IC50 > 12.5 μg/mL). Vitamin C, the positive control used in this assay, presented IC50 value equivalent to 1.7 μg/mL. 4-Nerolidylcatechol (IC50 = 0.4 μg/mL) and methylene chloride fraction (IC50 = 2.3 μg/mL) presented considerable cytotoxicity probably because of the presence of an o-quinone, an auto-oxidation by product of the catechol. Polar compounds, present in the ethanol extract, appear to increase the solubility and stability of the major active constituent, acting synergistically with 4-nerolidylcatechol, improving its pharmacokinetic parameters and increasing significantly its antioxidant activity which, in turn, suggests that the aqueous-ethanolic extract, used in folklore medicine, is safe and effective.
Natural Product Research | 2013
Bianca Souza Bagatela; Andrey Pereira Lopes; Fernando Luiz Affonso Fonseca; Márcio Adriano Andreo; Dhammika Nanayakkara; Jairo Kenupp Bastos; Fabio Ferreira Perazzo
Presently, natural products, such as Piper umbellata L. (Piperaceae), have been evaluated as sources of antimicrobial agents with efficacies against microorganisms. The in vitro antimicrobial activity was performed by broth micro-dilution susceptibility assay, according to the protocols of the National Committee for Clinical Laboratory Standards, and described the antibacterial and antifungal activities of crude ethanolic extract and fractions obtained by partitions sequentially among water–methanol, methylene chloride and ethyl acetate, as well as the major constituent, 4-nerolidylcatechol from the aerial parts of P. umbellata L. Amphotericin B and ciprofloxacin were used as controls. Among the microorganism cultures, hydromethanol fraction demonstrated the pre-eminent antifungal activity. 4-Nerolidylcathecol was the only tested plant component that exhibited activity against all the selected microorganisms, suggesting its great potential as a source for the development of new drugs. In order to estimate the antimalarial activity of P. umbellata L., a micro-dilution method protocol, parasite lactate dehydrogenase assay, with a Plasmodium falciparum Sierra Leone (D6) clone was utilised. The antimalarial agent artemisinin was used as control. 4-Nerolidylcathecol exhibited the best antimalarial activity; however, it was not significant when compared with control. These in vitro results do not justify the use of P. umbellata L. in malaria patients. However, there is a possibility of 4-nerolidylcathecol, after biotransformation, exhibiting a significant antimalarial activity in in vivo assays. However, 4-nerolidylcathecol demonstrated to possess a broad antimicrobial activity which is, in fact, a promising source for the development of new therapeutic agents.
Journal of Natural Products | 2014
Willian J. Andrioli; Raphael Conti; Magali J. Araújo; Riccardo Zanasi; Bruno C. Cavalcanti; Viviane Manfrim; Juliano S. Toledo; Daniele Tedesco; Manoel Odorico de Moraes; Cláudia Pessoa; Angela K. Cruz; Carlo Bertucci; José R. Sabino; Dhammika Nanayakkara; Mônica T. Pupo; Jairo Kenupp Bastos
Three new azaphilones with an unusual methylene bridge, named mycoleptones A, B, and C (2, 4, and 5), were isolated from cultures of Mycoleptodiscus indicus, a fungus associated with the South American medicinal plant Borreria verticillata. Additionally, four known polyketides, austdiol (1), eugenitin (3), 6-methoxyeugenin (6), and 9-hydroxyeugenin (7), were also isolated. The structural characterization of compounds was carried out by nuclear magnetic resonance spectroscopy, high-resolution mass spectrometry, electronic circular dichroism spectroscopy, time-dependent density functional theory calculations, and X-ray crystallography. Compounds 1-9 were weakly active when tested in antileishmanial and cytotoxicity assays.
Journal of Chromatography A | 2011
Ana Carolina Pereira; Lizandra Guidi Magalhães; Ana Helena Januário; Patrícia Mendonça Pauletti; Wilson Roberto Cunha; Jairo Kenupp Bastos; Dhammika Nanayakkara; Márcio Luis Andrade e Silva
(±)-Licarin A (1), a neolignan obtained by the oxidative coupling reaction of isoeugenol, had in this study its enantiomers resolved. A novel, quick and efficient enantiomeric resolution of 1 was directly performed by chiral high-performance liquid chromatography (HPLC-PDA) protocol (CHIRALPACK(®) AD column; 9:1 (v/v) n-hexane:2-propanol; 1.0 mL/min). This method provided a chromatogram profile with a well-resolved peak separation. After isolation of each enantiomer with ee>99.9%, they were analysed in a polarimeter. Compound 2, which showed a retention time (t(r)) of 12.13 min, was the (+)-enantiomer and compound 3 (t(r)=18.90 min) was the (-)-enantiomer.
Phytochemistry | 2014
Márcio Luis Andrade e Silva; Viviane Rodrigues Esperandim; Daniele da Silva Ferreira; Lizandra Guidi Magalhães; Thaís C. Lima; Wilson Roberto Cunha; Dhammika Nanayakkara; Ana Carolina Pereira; Jairo Kenupp Bastos
Parasitic diseases continue to be a major worldwide health problem, and there is an urgent need for development of therapeutic drugs. This paper describes synthesis of dehydrodiferulic acid dilactone 1 and dehydrodisinapic acid dilactone 2 furofuran lignans by oxidative coupling of ferulic and sinapic acids, respectively. Their schistosomicidal, trypanocidal, and leishmanicidal activities were evaluated in vitro against Schistosoma mansoni adult worms, trypomastigote and amastigotes forms of Trypanosoma cruzi, and promastigote forms of Leishmania amazonensis. Compound 1 did not display significant schistosomicidal activity, but it presented potent trypanocidal activity, since it induced death of trypomastigotes and amastigotes with IC50/24h of 9.3μM and 7.3μM, respectively. Compound 2 had slight trypanocidal and schistosomicidal activities. None of the compounds were active against L. amazonensis. These results demonstrated that furofuran lignans are potentially useful for anti-parasitic drugs development and should be further investigated.
Biological & Pharmaceutical Bulletin | 2007
Joanna Bajsa; Kshipra Singh; Dhammika Nanayakkara; Stephen O. Duke; Agnes M. Rimando; Antonio Evidente; Babu L. Tekwani
Revista Brasileira De Farmacognosia-brazilian Journal of Pharmacognosy | 2015
Marivane Lemos; José Roberto Santin; Cassia S. Mizuno; Thaise Boeing; João Paulo Barreto de Sousa; Dhammika Nanayakkara; Jairo Kenupp Bastos; Sérgio Faloni de Andrade
Archive | 2004
Kevin K Schrader; Dhammika Nanayakkara
Journal of Eukaryotic Microbiology | 1997
Margaret M. Shaw; James D. McChesney; Dhammika Nanayakkara; Luiza R. S. Dias; Chao-Hung Lee; Pamela J. Durant; Mark D. Ball; James W. Smith; Marilyn S. Bartlett